UPDATE - Barclays Starts Oil States Int'l (OIS) at Overweight; Diversified with Strong Underlying Trends
Get Alerts OIS Hot Sheet
Price: $8.65 -0.57%
Rating Summary:
13 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
13 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
UPDATE - Barclays initiates coverage on Oil States International (NYSE: OIS) with an Overweight. PT $115.00.
Analyst, Anthony Walker, said, "We believe OIS is a high-quality mid-cap company and a distinct way to gain exposure to the Canadian market, the Australian accommodations business and the global acceleration in offshore equipment demand. The Accommodations business is likely to be a primary beneficiary of a solid multi-year outlook for E&P spending growth in Canada driven by increased investments in the oil sands, potential LNG opportunities and the continued shift from gas-directed activity to oil- and liquids-rich drilling."
The company's positive business trends offer growth and visibility, therefore Barclays sees FY12 EPS at $7.75 and rising to $8.85 in 2013.
To see more ratings on OIS, Click Here
Analyst, Anthony Walker, said, "We believe OIS is a high-quality mid-cap company and a distinct way to gain exposure to the Canadian market, the Australian accommodations business and the global acceleration in offshore equipment demand. The Accommodations business is likely to be a primary beneficiary of a solid multi-year outlook for E&P spending growth in Canada driven by increased investments in the oil sands, potential LNG opportunities and the continued shift from gas-directed activity to oil- and liquids-rich drilling."
The company's positive business trends offer growth and visibility, therefore Barclays sees FY12 EPS at $7.75 and rising to $8.85 in 2013.
To see more ratings on OIS, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- TD Cowen Assumes Crescent Biopharma Inc (CBIO) at Buy
- TD Cowen Assumes Shattuck Labs (STTK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share